[
  {
    "ts": null,
    "headline": "CVS Health Corp. stock outperforms competitors on strong trading day",
    "summary": "CVS Health Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=3256ddc0883b5c8f68cd4fec8ef48e6d6d507831bdaf04d9f11b702938e79b1a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732121280,
      "headline": "CVS Health Corp. stock outperforms competitors on strong trading day",
      "id": 131604187,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=3256ddc0883b5c8f68cd4fec8ef48e6d6d507831bdaf04d9f11b702938e79b1a"
    }
  },
  {
    "ts": null,
    "headline": "Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy",
    "summary": "Top F500IL dividend stocks like AT&T, Altria, and Energy Transfer promise gains. Read why Energy Transfer stands as a safer choice.",
    "url": "https://finnhub.io/api/news?id=ccadc8f5e72aea70fa388baaa54e7a39c8e6cfc6c8a3c50207b5dc11274dde27",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732118725,
      "headline": "Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy",
      "id": 131518616,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2155502722/image_2155502722.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Top F500IL dividend stocks like AT&T, Altria, and Energy Transfer promise gains. Read why Energy Transfer stands as a safer choice.",
      "url": "https://finnhub.io/api/news?id=ccadc8f5e72aea70fa388baaa54e7a39c8e6cfc6c8a3c50207b5dc11274dde27"
    }
  },
  {
    "ts": null,
    "headline": "Is CVS Health Stock an Underrated Buy?",
    "summary": "Shares of healthcare giant CVS Health (NYSE: CVS) have been in a free fall this year.  The company has failed to impress investors with its earnings numbers and has slashed its guidance multiple times.  Is CVS stock worth the risk?",
    "url": "https://finnhub.io/api/news?id=b16486cd351e3e2d49c15f7f17bfd8dd1aac2f3eb548adbe76861d3a0323f25d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732115700,
      "headline": "Is CVS Health Stock an Underrated Buy?",
      "id": 131518522,
      "image": "https://g.foolcdn.com/editorial/images/798047/pharmacist-handing-prescription-medication-to-a-customer.jpg",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Shares of healthcare giant CVS Health (NYSE: CVS) have been in a free fall this year.  The company has failed to impress investors with its earnings numbers and has slashed its guidance multiple times.  Is CVS stock worth the risk?",
      "url": "https://finnhub.io/api/news?id=b16486cd351e3e2d49c15f7f17bfd8dd1aac2f3eb548adbe76861d3a0323f25d"
    }
  },
  {
    "ts": null,
    "headline": "Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day",
    "summary": "Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day.",
    "url": "https://finnhub.io/api/news?id=ec92c9b4ac59e9f47bbce1e2cd6972fbe053deb06ac6be773b2373f05242e56c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732108680,
      "headline": "Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day",
      "id": 131516311,
      "image": "https://media.zenfs.com/en/zacks.com/42dcb33abac72bc0b7fd94425cb3c63c",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day.",
      "url": "https://finnhub.io/api/news?id=ec92c9b4ac59e9f47bbce1e2cd6972fbe053deb06ac6be773b2373f05242e56c"
    }
  },
  {
    "ts": null,
    "headline": "Bear of the Day: CVS Health (CVS)",
    "summary": "Guidance cuts stemming from weak quarterly results have caused shares to travel a rocky road in 2024.",
    "url": "https://finnhub.io/api/news?id=d32235adaee2d4f02f85f7f851c82ef390949f0605167ddd9a78c4ea8982d136",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732096800,
      "headline": "Bear of the Day: CVS Health (CVS)",
      "id": 131518525,
      "image": "https://media.zenfs.com/en/zacks.com/d5b55460483116d75b81c6b47271a236",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Guidance cuts stemming from weak quarterly results have caused shares to travel a rocky road in 2024.",
      "url": "https://finnhub.io/api/news?id=d32235adaee2d4f02f85f7f851c82ef390949f0605167ddd9a78c4ea8982d136"
    }
  },
  {
    "ts": null,
    "headline": "XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)",
    "summary": "We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.",
    "url": "https://finnhub.io/api/news?id=fda1041225add2352abc51ab2126c9563bd38831235bdf55044cf40be42ddef3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732093680,
      "headline": "XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)",
      "id": 131502070,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1496411389/image_1496411389.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.",
      "url": "https://finnhub.io/api/news?id=fda1041225add2352abc51ab2126c9563bd38831235bdf55044cf40be42ddef3"
    }
  },
  {
    "ts": null,
    "headline": "Oak Street Health co-founder departs CVS",
    "summary": "Mike Pykosz, who joined CVS with its acquisition of the value-based medical chain in 2023, is departing amid a flurry of high-level ousters at the struggling company. However, Pykosz is leaving voluntarily, CVS said.",
    "url": "https://finnhub.io/api/news?id=29e12baa3d742ec57c9b94817d19d7f6e58dfc2f36c69c833ee8ecb2e68a8bd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732091360,
      "headline": "Oak Street Health co-founder departs CVS",
      "id": 131518527,
      "image": "https://imgproxy.divecdn.com/eijjaGJ40eHvV0BsjkppH2VAYdJqEoTuXhkwuxtcmUM/g:nowe:0:714/c:4815:2720/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTE0MTM2OTMyMDguanBn.webp",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Mike Pykosz, who joined CVS with its acquisition of the value-based medical chain in 2023, is departing amid a flurry of high-level ousters at the struggling company. However, Pykosz is leaving voluntarily, CVS said.",
      "url": "https://finnhub.io/api/news?id=29e12baa3d742ec57c9b94817d19d7f6e58dfc2f36c69c833ee8ecb2e68a8bd1"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys",
    "summary": "Investment activity in October focused on Business Development Companies. Check out my portfolio, my main picks, and my target for 2024.",
    "url": "https://finnhub.io/api/news?id=ee2c0c1844905ec03a4c7fe82d622e1f1a4eac7b2c437722a3c253267dbcb25d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732090200,
      "headline": "My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys",
      "id": 131501184,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Investment activity in October focused on Business Development Companies. Check out my portfolio, my main picks, and my target for 2024.",
      "url": "https://finnhub.io/api/news?id=ee2c0c1844905ec03a4c7fe82d622e1f1a4eac7b2c437722a3c253267dbcb25d"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Sustainable U.S. Value Equity Fund Q3 2024 Commentary",
    "summary": "The BlackRock Sustainable U.S. Value Equity Fund posted returns of 4.64% (Institutional shares) for the third quarter of 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=1cc069113562878d229d7aff1cd0469f43b3b8668e703a31b8432959ef03e6ad",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732086600,
      "headline": "BlackRock Sustainable U.S. Value Equity Fund Q3 2024 Commentary",
      "id": 131499938,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1481304981/image_1481304981.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The BlackRock Sustainable U.S. Value Equity Fund posted returns of 4.64% (Institutional shares) for the third quarter of 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=1cc069113562878d229d7aff1cd0469f43b3b8668e703a31b8432959ef03e6ad"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Equity Dividend Fund Q3 2024 Commentary",
    "summary": "BlackRock Equity Dividend Fund posted returns of 6.39% (Institutional shares) and 6.31% (Investor A shares, without sales charge) for the third quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=a8522b7b86b4ac3859bc72ea068eb5f487ea32a28f4e2099c11b0f4826586127",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732078980,
      "headline": "BlackRock Equity Dividend Fund Q3 2024 Commentary",
      "id": 131497984,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1158571563/image_1158571563.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "BlackRock Equity Dividend Fund posted returns of 6.39% (Institutional shares) and 6.31% (Investor A shares, without sales charge) for the third quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=a8522b7b86b4ac3859bc72ea068eb5f487ea32a28f4e2099c11b0f4826586127"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Basic Value V.I. Fund Q3 2024 Commentary",
    "summary": "The BlackRock Basic Value V.I. Fund posted a return of 6.38% (Class I shares) for the third quarter of 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=802399821c886ea8a233c8e0e40438dfe8211ec00d13d1d099902a007fdbb266",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732076100,
      "headline": "BlackRock Basic Value V.I. Fund Q3 2024 Commentary",
      "id": 131497378,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1365758819/image_1365758819.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The BlackRock Basic Value V.I. Fund posted a return of 6.38% (Class I shares) for the third quarter of 2024. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=802399821c886ea8a233c8e0e40438dfe8211ec00d13d1d099902a007fdbb266"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Equity Dividend V.I. Fund Q3 2024 Commentary",
    "summary": "The BlackRock Equity Dividend V.I. Fund posted a return of 6.49% (Class I shares) for the third quarter of 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=b45526755dd0df8ba118c21b34faf9d4082d1a18a8caf11c2148082129153740",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732068300,
      "headline": "BlackRock Equity Dividend V.I. Fund Q3 2024 Commentary",
      "id": 131496241,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400960132/image_1400960132.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The BlackRock Equity Dividend V.I. Fund posted a return of 6.49% (Class I shares) for the third quarter of 2024. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=b45526755dd0df8ba118c21b34faf9d4082d1a18a8caf11c2148082129153740"
    }
  }
]